Dissertation > Excellent graduate degree dissertation topics show

Association between Thrombin Activatable Fibrrinolysis Inhibitor and Breast Cancer

Author: XuChengWei
Tutor: WangYunShan
School: Shandong University
Course: Clinical Laboratory Science
Keywords: Breast cancer Thrombin activatable fibrinolysis inhibitor Geneticpolymorphisms Thr325lleBreast cancer Thrombin-activatable fibrinolysis inhibitor RNAnterference Transwell assay
CLC: R737.9
Type: PhD thesis
Year: 2013
Downloads: 29
Quote: 0
Read: Download Dissertation


Part I Clinical investigationObjective The aim of this study was to investigate if thrombin activatable fibrinolysis inhibitor antigen and activity (TAFI Ag and TAFI Act) levels and TAFI Thr325lle and Thr147Ala polymorphism could be a risk marker of breast cancer in Chinese Han patients.Methods:The plasma TAFI Ag and Act was determined using ELISA and chromogenic assay in256patients with breast cancer and192healthy controls. Besides fibrinogen and D-dimer levels were routinely measured, TAFI Thr325lle (rs1926447) and Thr147Ala (rs3742264) polymorphism was genotyped in both patient and control groups using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.Results:TAFI Ag and Act levels were significantly higher in breast cancer patients than in controls (100.6±15.2%vs82.7±11.2%and30.5±2.8μg/ml vs23.5±1.6μg/ml, P<0.001respectively). The plasma fibrinogen and D-dimer levels were also significant increased in comparison with those in controls (3.7±1.2g/L vs.2.6±1.4g/L and598.5±115.3ng/mL vs.125.2±55.4ng/mL, P<0.001, respectively). TAFI Ag levels are correlated with metastasis of breast cancer (P<0.001). The Thr/lle (CT) and lle/lle (TT) genotypes were more frequently in patients group compared with the control group [OR:2.106;(95%CI:1.379-3.217); P<0.001]. The high-risk T alleles frequency was also higher in patients compared with healthy controls [OR:1.718;(95%CI:1.316-2.243); P<0.001]. The polymorphism was significantly correlated with TAFI Ag levels in either group (P<0.001). The lle/lle (TT) genotype had the lowest TAFI Ag level, while the Thr/Thr (CC) had the highest one. Thr147Ala gene polymorphism in the case group and control group in the frequency distribution, as well as TAFI antigen level were no significant difference.Conclusions:The plasma TAFI levels and TAFI Thr325lle genotypes were associated with breast cancer patients in Chinese Han populations and can be considered as the risk markers of breast cancer. Patients with breast cancer are at high risk of high coagulation state, which pathogenesis is complex involves both coagulation activation and fibrinolytic inhibition. Part Ⅱ Experiment researchObjective To investigate the effects of CPB2gene silencing on thrombin activated fibrinolysis inhibitor (TAFI) expression and metastatic in the breast cancer cell line MDA-MB-231.Methods Based on the sequence of CPB2, three siRNA were designed and chemically synthesized. They were transfected into the breast cancer cell line MDA-MB-231with LipofectamineTM2000. The TAFI mRNA and protein levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Cell invasive and metastasis ability and growth inhibition were determined by transwell assay and MTT assay.Results siRNAs targeting CPB2significantly down-regulated the mRNA and the protein level of TAFI (P<0.05), and the inhibition ratio range from55.4%to42.6%. The growth of breast cell line MDA-MB-231were inhibited (P<0.05) and the invasive and metastasis ability were also significantly inhibited compared to the control group (P<0.05).Conclusions CPB2-siRNA can significantly down-regulate TAFI expression in transcriptional and translational levels, inhibit cell growth, invasive and metastasis ability in the breast cell line MDA-MB-231. It can be used as a new target for the breast cancer in therapy of metastasis.

Related Dissertations

  1. The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
  2. The Related Study of Breast-conserving Surgery Plus Postoperative Tangential Irradiation,R737.9
  3. The Relevance Research between Breast Cancer Calcification X Performance and Pathology,R737.9
  4. Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
  5. The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
  6. Expressions of HOXA9 HOXA10 and HOXA11 in Breast Cancer,R737.9
  7. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
  8. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  9. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  10. The Expression and Significance of Parathyroid Hormone-related Protein in Human Breast Cancer with Skeletal Metastases,R737.9
  11. The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
  12. Analysis of Clinial and Patholgoic Characteristics between the Han and the Uygur Patients with Triple-negative Breast Cancer,R737.9
  13. Clinical Signifinance of Combined Detection of Tumor Markers in Breast Cancer,R737.9
  14. Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
  15. Mammographic X-ray analysis of false-negative breast cancer,R737.9
  16. Epidermal growth factor in breast carcinoma and its clinical significance 1,2,R737.9
  17. CK5 / 6 and EGFR as triple negative breast cancer prognostic factors analysis,R737.9
  18. A Retrospective Study on Chemotherapy-induced Amenorrhea in Premenopausal Women with Breast Cancer,R737.9
  19. The Expression and Clinical Significance of Stem Cell-related Markers CD44 and CD24 in Breast Cancer,R737.9
  20. The Correlation Research of Dynamic Contrast-enhanced MR and Diffusion Weighted Imaging with Histopathology and Molecular Biology in Breast Cancer,R737.9
  21. Screening Results of Breast Cancer among 10004 Women in Zunyi City in 2009,R737.9

CLC: > Medicine, health > Oncology > Genitourinary tumors > Breast tumor
© 2012 www.DissertationTopic.Net  Mobile